Clinical trials that compare a new drug to treat moderate-to-severe attacks of hereditary angioedema with placebo raise concerns. Cicardi et al. cite previous studies 1,2 and state, “Replacement therapy with intravenous C1 esterase-inhibitor concentrate reverses acute attacks.” [Carta] (2011)
- Authors:
- Autor USP: KALIL FILHO, JORGE ELIAS - FM
- Unidade: FM
- Subjects: DOENÇAS HEREDITÁRIAS; PLACEBOS (ADMINISTRAÇÃO E DOSAGEM); ANGIOEDEMA (GENÉTICA;TERAPIA)
- Language: Inglês
- Imprenta:
- Source:
- Título: New England Journal of Medicine
- ISSN: 0028-4793
- Volume/Número/Paginação/Ano: v. 364, n. 1, p. 84-85, 2011
-
ABNT
GIAVINA-BIANCHI, Pedro e MOTTA, Abílio e KALIL FILHO, Jorge. Clinical trials that compare a new drug to treat moderate-to-severe attacks of hereditary angioedema with placebo raise concerns. Cicardi et al. cite previous studies 1,2 and state, “Replacement therapy with intravenous C1 esterase-inhibitor concentrate reverses acute attacks.” [Carta]. New England Journal of Medicine. Boston: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 08 out. 2024. , 2011 -
APA
Giavina-Bianchi, P., Motta, A., & Kalil Filho, J. (2011). Clinical trials that compare a new drug to treat moderate-to-severe attacks of hereditary angioedema with placebo raise concerns. Cicardi et al. cite previous studies 1,2 and state, “Replacement therapy with intravenous C1 esterase-inhibitor concentrate reverses acute attacks.” [Carta]. New England Journal of Medicine. Boston: Faculdade de Medicina, Universidade de São Paulo. -
NLM
Giavina-Bianchi P, Motta A, Kalil Filho J. Clinical trials that compare a new drug to treat moderate-to-severe attacks of hereditary angioedema with placebo raise concerns. Cicardi et al. cite previous studies 1,2 and state, “Replacement therapy with intravenous C1 esterase-inhibitor concentrate reverses acute attacks.” [Carta]. New England Journal of Medicine. 2011 ; 364( 1): 84-85.[citado 2024 out. 08 ] -
Vancouver
Giavina-Bianchi P, Motta A, Kalil Filho J. Clinical trials that compare a new drug to treat moderate-to-severe attacks of hereditary angioedema with placebo raise concerns. Cicardi et al. cite previous studies 1,2 and state, “Replacement therapy with intravenous C1 esterase-inhibitor concentrate reverses acute attacks.” [Carta]. New England Journal of Medicine. 2011 ; 364( 1): 84-85.[citado 2024 out. 08 ] - Rejection of grafts with no H-2 disparity in TAP1 mutant mice:: CD4 T cells are important effector cells and self H-2b class I molecules are target
- T cell reactivity to HSP60 in murine model of vascularized heart allografting
- Locally produced IL-15 may underlie the predominance of CD8+IL2RALPHA- T cells ar heart lesions of human Chagas Disease cardiomyopathy
- Transplante cardíaco para tratamento da miocardiopatia chagásica
- Distribution of primary immunodeficiency diseases at University of Sao Paulo Medical School, Brazil
- Comparison between indirect allo-proliferative response and binding prediction to HLA-DR molecules by tepitope analysis
- In vitro expansion of long-term CD8+ T cell lines from chagasic patients is dependent on IL-15
- Evaluation of different transplantation tolerance schedule with HSP in murine skin allograft
- Sensitization to aeroallergens: urban/rural differences in São Paulo-Brazil
- Rheumatic heart disease: intralesional T cells recognize peptides from cardiac myosin beta chain
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
